Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials
Clinical and Experimental Gastroenterology · 2024-04 · Volume 17 · 121-134
DOI: 10.2147/ceg.s390655 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Gastroenterology, 2024-04. Verfasst von Robin Imperial und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NCI NIH HHS, NIMHD NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL, USA.
- Department of Medical Oncology, Rochester, MN, USA.
- Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
ORCID-Profile: Osama Mosalem
Förderung
- NCI NIH HHS
- NIMHD NIH HHS
Zitieren
APA
Imperial, R., Mosalem, O., Majeed, U., Tran, N. H., Borad, M. J., & Babiker, H. (2024). Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials. Clinical and Experimental Gastroenterology, Volume 17, 121-134. https://doi.org/10.2147/ceg.s390655
Vancouver
Imperial R, Mosalem O, Majeed U, Tran NH, Borad MJ, Babiker H. Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials. Clinical and Experimental Gastroenterology. 2024;Volume 17:121-134. doi:10.2147/ceg.s390655
BibTeX
@article{Imperial2024,
author = {Imperial, Robin and Mosalem, Osama and Majeed, Umair and Tran, Nguyen H and Borad, Mitesh J and Babiker, Hani},
title = {Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials},
journal = {Clinical and Experimental Gastroenterology},
year = {2024},
volume = {Volume 17},
pages = {121--134},
doi = {10.2147/ceg.s390655}
}
EUVIMED